bpc 157 oral spray BPC-LX™ Pro Oral vs Injectable BPC-157: Differences,
Description
So, this product is excellent
3 The adverse drug reaction incidence rate was 1.6% (1/64 cases) in the placebo group and 7.7% (5/65 cases) in the mecobalamin 50 mg group
Anyone considering BPC-157 should consult a qualified physician and be aware of the severe risks related to injecting non-pharmaceutical-grade compounds
We use small needles and careful technique to make the experience as comfortable as possible
